Wong Ming-Wun, Liu Tso-Tsai, Yi Chih-Hsun, Lei Wei-Yi, Hung Jui-Sheng, Cock Charles, Omari Taher, Gyawali Chandra Prakash, Liang Shu-Wei, Lin Lin, Chen Chien-Lin
Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan.
School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien, Taiwan.
Aliment Pharmacol Ther. 2021 Oct;54(7):923-930. doi: 10.1111/apt.16561. Epub 2021 Aug 12.
BACKGROUND: The pathogenesis of gastro-oesophageal reflux disease (GERD) is complex and multifactorial. The oesophageal hypervigilance and anxiety scale (EHAS) is a novel cognitive-affective evaluation of visceral sensitivity. AIMS: To investigate the interrelationship between EHAS and reflux symptom severity, psychological stress, acid reflux burden, phenotypes, and oesophageal mucosal integrity in patients with GERD. METHODS: Patients with chronic reflux symptoms and negative endoscopy underwent 24-hour impedance-pH monitoring for phenotyping, acid reflux burden, and mucosal integrity with mean nocturnal baseline impedance (MNBI) calculation. Validated scores for patient-reported outcomes, including EHAS, GERD questionnaire (GERDQ), State-Trait Anxiety Inventory score, and Taiwanese Depression Questionnaire score, were recorded. RESULTS: We enrolled 105 patients, aged 21-64 years (mean, 48.8), of whom 58.1% were female; 27 had non-erosive reflux disease, 43 had reflux hypersensitivity and 35 had functional heartburn. There were no significant differences in sex, EHAS, GERDQ, questionnaires of depression or anxiety among GERD phenotypes. EHAS was significantly correlated with GERDQ, questionnaires of depression and anxiety (P < 0.05). However, there were no significant correlations between GERDQ and questionnaires of depression or anxiety. Regarding patient-reported outcomes, GERDQ positively correlated with acid exposure time and negatively correlated with MNBI (P < 0.05). CONCLUSIONS: EHAS associates with reflux symptom severity and psychological stress but not with acid reflux burden or mucosal integrity. Thus, EHAS assessment shows promise in assessment of subjective patient outcome and satisfaction with treatment, a hitherto unmet clinical need.
背景:胃食管反流病(GERD)的发病机制复杂且具有多因素性。食管高敏和焦虑量表(EHAS)是一种对内脏敏感性的新型认知 - 情感评估方法。 目的:研究GERD患者中EHAS与反流症状严重程度、心理压力、酸反流负荷、表型及食管黏膜完整性之间的相互关系。 方法:有慢性反流症状且内镜检查阴性的患者接受24小时阻抗 - pH监测,以进行表型分析、酸反流负荷评估及通过计算平均夜间基线阻抗(MNBI)评估黏膜完整性。记录包括EHAS、GERD问卷(GERDQ)、状态 - 特质焦虑量表得分及台湾抑郁问卷得分等经过验证的患者报告结局评分。 结果:我们纳入了105例年龄在21 - 64岁(平均48.8岁)的患者,其中58.1%为女性;27例患有非糜烂性反流病,43例患有反流高敏,35例患有功能性烧心。GERD各表型之间在性别、EHAS、GERDQ、抑郁或焦虑问卷方面无显著差异。EHAS与GERDQ、抑郁和焦虑问卷显著相关(P < 0.05)。然而,GERDQ与抑郁或焦虑问卷之间无显著相关性。关于患者报告结局,GERDQ与酸暴露时间呈正相关,与MNBI呈负相关(P < 0.05)。 结论:EHAS与反流症状严重程度和心理压力相关,但与酸反流负荷或黏膜完整性无关。因此,EHAS评估在评估患者主观结局和治疗满意度方面显示出前景,这是迄今尚未满足的临床需求。
Am J Gastroenterol. 2023-5-1
Aliment Pharmacol Ther. 2018-3-12
Neurogastroenterol Motil. 2021-6
Aliment Pharmacol Ther. 2013-1-7
Clin Res Hepatol Gastroenterol. 2021-3
J Neurogastroenterol Motil. 2025-7-30
World J Gastroenterol. 2025-5-7
Am J Gastroenterol. 2025-4-7
Aliment Pharmacol Ther. 2025-5
Transl Gastroenterol Hepatol. 2024-6-17